Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes

Kogieleum Naidoo(Centre for the AIDS Programme of Research in South Africa), Salim S. Abdool Karim(Centre for the AIDS Programme of Research in South Africa), Mikaila C. Moodley(Centre for the AIDS Programme of Research in South Africa), Razia Hassan-Moosa(Centre for the AIDS Programme of Research in South Africa), Navisha Dookie(South African Medical Research Council), Rubeshan Perumal(South African Medical Research Council), Nomonde R. Mvelase(National Health Laboratory Service), Nonhlanhla Yende‐Zuma(Centre for the AIDS Programme of Research in South Africa), Barun Mathema(Rutgers, The State University of New Jersey), Halima Dawood(Centre for the AIDS Programme of Research in South Africa)
Clinical Infectious Diseases
March 4, 2022
10.1093/cid/ciac185
Cited by 16

Related Papers

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
|Nature|2021|1.2k
The Impact of Migration on HIV-1 Transmission in South Africa
|Sexually Transmitted Diseases|2003|460
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
|medRxiv|2021|366
Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa
|AIDS|2003|319
Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal
|PLoS Medicine|2015|299